US Patent Issued to AstraZeneca on Feb. 17 for "PCSK9 inhibitors and methods of use thereof" (British, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,807, issued on Feb. 17, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"PCSK9 inhibitors and methods of use thereof" was invented by Michael H. Serrano-Wu (Belmont, Mass.), Mark Chambers (Cambridge, Great Britain), Erica Goldsmith (Cambridge, Great Britain), Jason Tierney (Cambridge, Great Britain), Karamjit Jandu (Cambridge, Great Britain), David Clark (Cambridge, Great Britain) and Paul Hinchliffe (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to novel heteroaryl compounds of Formula (I), and pharmaceutically acceptable salts thereof; and pharmaceutical preparations thereof. The invention furth...